Overview

Sugammadex Vs Neostigmine in Reversing Neuromuscular Blocks in Outpatient ERCP. A Randomized, Double-Blinded Trial

Status:
Not yet recruiting

Trial end date:
2025-10-31

Target enrollment:

Participant gender:

Summary

The investigators propose a single-center,assessor-Blinded, parallel group randomized trial to compare the efficacy of reversal of rocuronium induced neuromuscular blockade by sugammadex versus neostigmine in patients undergoing Endoscopic retrograde cholangiopancreatography at Cleveland Clinic Main Campus.

Phase:

N/A

Details

Lead Sponsor:

The Cleveland Clinic

Collaborator:

Merck Sharp & Dohme LLC

Treatments:

Neostigmine